Peptide Maker AmbioPharm Plans $18.8 M Expansion
AmbioPharm, Inc. (APi) a company specializing in peptide manufacturing, is expanding its existing operations in Aiken County, South Carolina through an $18.8 million investment for additional manufacturing suites and a new world headquarters on the existing 32 acres that APi owns. In total, the new additions will add approximately 40,000 square feet to the company’s existing facility in North Augusta, South Carolina.
The expansion in North Augusta is anticipated to be completed by the third quarter of 2018.
APi started its business in South Carolina in 2007, by establishing its company headquarters and downstream manufacturing operations in a 10,000-square-foot facility in the North Augusta Industrial Park. That same year, APi also opened its Shanghai, China operations, which focuses on synthesis, as well as the research and development of pharmaceutical products. In 2014, the company made facility expansions by adding 10,000 square feet in North Augusta and 18,000 square feet in Shanghai. Between the two facilities, the company now employs more than 200 workers. The new expansion is expected to create 100 new jobs.
